Rx Prices For Medicare, Non-Medicare Groups Show Similar Growth – GAO
Executive Summary
Retail prices for drugs frequently used by Medicare enrollees are increasing at a "similar" rate to those used by the non-Medicare population, the Government Accountability Office said
You may also be interested in...
GAO Drug Price Study Finds Fraction Of Products Accounts For Most Increases
A Government Accountability Office study of drug prices found that a limited number of drugs were responsible for the vast majority of drug price increases between 2000 and 2004
GAO Drug Price Study Finds Fraction Of Products Accounts For Most Increases
A Government Accountability Office study of drug prices found that a limited number of drugs were responsible for the vast majority of drug price increases between 2000 and 2004
PhRMA Studies Contest AARP Drug Price “Watchdog Report”
Prescription drug prices rose only 0.9% in the first quarter of 2004, not 3.4% as AARP claims, a study of Bureau of Labor Statistics data commissioned by the Pharmaceutical Research & Manufacturers of America says